DXBO
Asset Logo

Dimerix Limited

πŸ‡¦πŸ‡Ί ASX

Compare
Add to watchlist
πŸ‘‘ Overview

πŸ“ˆ Performance

πŸ’΅ Cost

πŸ€“ Advanced

πŸ‘¨β€πŸ‘©β€πŸ‘§β€πŸ‘¦ Community

πŸ“ˆ

N/A
Annual Growth

5 years average annual growth

πŸ’΅

$ 500
Minimum Order

Due to regulatory requirements

🌏

0
Pearlers Invested

Since January 2020

πŸ‘‘ Overview

Key information
πŸ”Ž Fund Overview

Dimerix Limited - Option Expiring 30-Jun-2025

πŸ“ˆ Performance

Price History

N/A

1M

1Y

All Time

Graph

Table

Unsure how much or often to invest?
πŸ—“οΈ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out β†’
πŸ’΅ Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out β†’
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out β†’

πŸ’΅ Costs

πŸ’΅

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

πŸ’Ό

N/A
Management Fee

Included in unit price, not charged by Pearler

πŸ’Έ

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
πŸ’Έ Net fee calculator

πŸ€“ Advanced information

Technical Info

πŸ’° Price*

$0.20

*Price may be up to 24 hours old

πŸ‘©β€πŸ‘©β€πŸ‘¦ Community Insights

How our community is investing

🌏 Pearlers invested in DXBO

0

πŸ“Š Total Capital Earnings

N/A

πŸ”ƒ Average investment frequency

N/A

πŸ’΅ Average investment amount

N/A

⏰ Last time a customer invested in DXBO

N/A
DXBO investor breakdown
πŸ’΅ Income of investors

More than 200k

150k - 200k

100k - 150k

50k - 100k

Less than 50k

πŸ‘Ά Age of investors

18 - 25

26 - 34

35 - 90

πŸ™‹ Legal gender of investors

Female

Male

Pearlers who invest in DXBO also invest in...

Want more shares? Try these...

Dexus Convenience Retail REIT

DXC

Dexus Convenience Retail REIT engages in owning and management of portfolio of properties. The company is headquartered in Sydney, New South Wales and currently employs 0 full-time employees. The company went IPO on 2017-07-27. The Fund's portfolio is valued at approximately $781 million, is predominantly located on Australia's eastern seaboard and leased to Australian and international convenience retail tenants. The portfolio has a long weighted average lease expiry and contracted annual rent increases, providing a high level of income security. The Fund has a conservative approach to capital management with a target gearing range of 25-40%. The Fund consists of three registered managed investment schemes domiciled in Australia: Convenience Retail REIT No. 1, Convenience Retail REIT No. 2 and Convenience Retail REIT No. 3. The Fund's manager is Convenience Retail Management Pty Ltd.

πŸ™Œ Performance (5Yr p.a)

-2.71%

πŸ“Š Share price

$2.93 AUD

🏠 REAL ESTATE

πŸ’° HIGH DIVIDEND

Find Out More

Dexus Industria REIT is an Australian real estate investment trust, which engages in interests in a workspace focused portfolio of several established, industrial, technology park and business park assets. The company is headquartered in Sydney, New South Wales. The company went IPO on 2013-12-03. The Trust is primarily engaged in investing in industrial warehouses located across Sydney, Melbourne, Brisbane, Perth and Adelaide. The Trust’s investment property portfolio consists of approximately 91 properties valued at $1.4 billion and is located across the major Australian cities. The company has a target gearing range of 30 - 40%. Its properties include 12 Church Road, Moorebank; 1-3 Westrac Drive, Newcastle; 7 Clunies Ross Court and 17-19 McKechnie Drive, Eight Mile Plains; 8 Clunies Ross Court and 9 McKechnie Drive, Eight Mile Plains; 18 Brandl Street, Eight Mile Plains; 37 Brandl Street, Eight Mile Plains; 88 Brandl Street, Eight Mile Plains; Brisbane Technology Park, Central, Eight Mile Plains; 9 Boron Street, Narangba; 60 Grindle Road, Wacol; 5 Butler Boulevard, Adelaide Airport; 5b Butler Boulevard, Adelaide Airport, and 45-65 O'Briens Road, Corio. Its manager is Dexus Asset Management Limited.

πŸ™Œ Performance (5Yr p.a)

-1.29%

πŸ“Š Share price

$2.67 AUD

🏠 REAL ESTATE

🌳 ENVIRONMENTAL

πŸ•ŠοΈ SOCIALLY AWARE

πŸ’° HIGH DIVIDEND

Dimerix Ltd. engages in the investment of the research and development of biopharmaceutical drugs. The company is headquartered in Melbourne, Victoria. The firm is focused on developing lives of patients with inflammatory diseases, including both kidney and respiratory diseases. The company develops and commercializes patient preferred pharmaceutical products for global markets using its receptor technology to identify and develop drugs in areas with an unmet need. The firm is focused on developing its Phase III product candidate DMX-200 (QYTOVRA), for Focal Segmental Glomerulosclerosis (FSGS) kidney disease and is also developing DMX-700 for Chronic Obstructive Pulmonary Disease (COPD). Its Receptor Heteromer Investigation Technology (Receptor-HIT) is a scalable and globally applicable technology platform enabling the understanding of receptor interactions to rapidly screen and identify new drug opportunities. Its products target multiple global territories, with the initial focus predominantly on the United States and European markets.

πŸ™Œ Performance (5Yr p.a)

42.73%

πŸ“Š Share price

$0.34 AUD

🧬 BIOTECHNOLOGY

πŸ“ˆ HIGH PRICE GROWTH

Compare
Add to watchlist